グルカゴン療法市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00019997
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場概要

グルカゴンは、ベータ遮断薬およびカルシウムチャネル遮断薬の過剰摂取、エピネフリンに抵抗性のアナフィラキシーに対する解毒剤として、低血糖の管理および治療に使用される薬剤です。 、そして食塊の通過を助けます。これは、急性低血糖症、ベータ遮断薬、カルクンチャネル遮断薬の過剰摂取、難治性アナフィラキシー、およびフーフによる食道閉塞を管理するための貴重な薬剤としてのグルカゴンの適応症、作用、および禁忌を説明する作用を持つ抗低血糖症クラスの薬剤です。ボーラス。さらに、そのようなグルカゴン活性は、適応症の患者を管理する際の医療チームメンバーに関連する作用機序、有害事象プロファイル、およびその他の重要な要素(適応外使用、投与量、薬力学、薬物動態、モニタリング、および関連する相互作用など)を浮き彫りにします。 .

市場範囲

「2031 年までの世界のグルカゴン療法市場分析」は、専門的で詳細な調査です。特に世界市場のトレンド分析に重点を置いた、ヘルスケア業界の研究を行っています。このレポートの目的は、グルカゴン療法市場の概要と、製品、用途、エンドユーザーに基づいた詳細な市場セグメンテーションを提供することです。さらに、このレポートは、主要なグルカゴン療法市場プレーヤーの市場状況に関する重要な統計、および主要な市場動向と機会を提供します。

市場セグメンテーション

  • 製品に基づいて、市場は注射剤と経鼻剤に二分されます。
  • アプリケーションに基づいて、市場は一般用途、診断用、および医療用途に分類されます。可動性、心原性ショックなど。
  • エンド ユーザーに基づいて、市場は病院と専門クリニックに分類されます。

市場のダイナミクス

ドライバー

  • 心臓疾患に苦しむ人の数の増加は、心臓病の最も影響力のある要因の 1 つです。世界のグルカゴン療法市場の成長に貢献します。
  • 究極の成長を担う市場では、ライフスタイルの変化と不健康な食生活が大きな注目を集めています。

拘束

  • 血糖値管理の重要性を理解する意識の欠如が、市場全体の成長鈍化の最も影響力のある要因として機能します。

地域フレームワーク

このレポートは、定性的データと定量的データの両方を含む業界の包括的な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、5 つの主要地域の市場規模と予測推定値も提供します。 、すなわち、2021年から2031年までの北米、ヨーロッパ、アジア太平洋(APAC)、中東およびアフリカ(MEA)、および南中米(SACA)。各地域のグルカゴン療法市場は、それぞれの国とセグメントによってさらに細分化されています。このレポートは、世界 18 か国を分析および予測するとともに、この地域の現在の傾向と機会を分析します。

レポートは、需要側と供給側の両方に影響を与える市場要因、および推進要因、制約、機会、将来の傾向など、予測期間中に市場に影響を与える市場ダイナミクスを分析します。北米、ヨーロッパ、APAC、MEA、中南米の 5 つの地域のグルカゴン療法市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後、これらの地域のそれぞれについて包括的な PEST 分析を実施します。

グルカゴン療法市場に対する新型コロナウイルス感染症(COVID-19)の影響

臨床研究では、SARS-CoV-2 の重要な酵素を標的としてウイルス量を減少させ、ウイルス排出。糖尿病と新型コロナウイルス感染症(COVID-19)の相互作用は依然として進化している。したがって、研究では、ACE2の役割と、糖尿病患者における新型コロナウイルス感染症の重症度の増加が明確に確立された。さらに、DPP4の役割はMERS-CoVに関与していると考えられているSARS-CoV-2 は同じサブファミリーおよびファミリーに属しているため、この病因が SARS-CoV-2 に関係している可能性がある一方、抗糖尿病薬はそのプロセスを軽減し、良好な血糖コントロールを達成できますが、その中でもインスリンは血糖管理において特に重要です。糖尿病に苦しむ COVId-19 患者、特に高血糖の緊急事態や ICU 患者の入院に苦しむ患者。このような前述の要因が、2022 年から 2031 年の予測期間中の新型コロナウイルス感染症患者の中での市場全体の成長の原因となる可能性があります。< /p>

市場参加者

このレポートでは、有機成長戦略と無機成長戦略などの 2 つの主要戦略に焦点を当てて、グルカゴン療法市場の主要な展開について取り上げています。さまざまな企業が、新製品の発売や製品承認などの有機成長戦略に焦点を当てています。無機的な成長戦略活動には、通常、戦略的買収、企業間のパートナーシップやコラボレーションが含まれます。これらの活動は、市場参加者のビジネスと顧客ベースの拡大への道を切り開いてきました。グルカゴン療法市場の支払者は、世界市場でのグルカゴン療法の需要の高まりにより、将来的に有利な成長機会を得ることが期待されています。

レポートには、グルカゴン療法市場における主要企業の SWOT 分析と市場戦略とともに、主要企業のプロフィールも含まれています。また、レポートは、企業プロフィール、コンポーネント、提供されたサービス、過去 3 年間の財務情報、過去 5 年間の主要な開発。

  • Xeris Biopharma Holdings, Inc.
  • SVAR
  • ノボ ノルディスク A/S
  • エリリリー
  • タージ ファーマシューティカルズ リミテッド
  • フレゼニウス カビ
  • トレント ファーマシューティカルズ リミテッド
  • Ferozsons Laboratories Limited
  • Zealand Pharma A/S
  • Amphastar Pharmaceuticals, Inc.

Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供します。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is expected to witness the second highest growth in CAGR terms?

Europe region is expected to witness a high growth rate in terms of CAGR after Asia Pacific region during the forecast period

Which region is expected to witness the highest growth?

Asia Pacific region is expected to witness the highest growth during the forecast period

What is the expected CAGR of the Glucagon Therapy Market?

The Glucagon Therapy Market is estimated to witness a CAGR of 6.4% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Xeris Pharmaceuticals Inc.
2. Svar Life Science AB
3. Novo Nordisk A/S
4. Lilly
5. Taj Pharmaceuticals Ltd
6. Fresenius SE and Co. KGaA
7. Torrent Pharmaceuticals Ltd
8. Ferozsons Laboratories Limited
9. Zealand Pharma A/S
10. Amphastar Pharmaceuticals, Inc


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.